Clinical trial
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx® System® at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
NCT01644669 is registered in ClinicalTrials.gov with Xoft, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx® System® at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
- Lead sponsor
- Xoft, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 8, 2012
- Completion date
- December 31, 2029
- Enrollment
- 1,200 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
ductal carcinoma in situ, invasive ductal carcinoma